Gestational Diabetes Mellitus-Induced Inflammation in the Placenta via IL-1β and Toll-like Receptor Pathways

• Published in: International journal of molecular sciences 2024-11, Vol.25 (21), p.11409
• Main Authors: Zgutka, Katarzyna, Tkacz, Marta, Tomasiak, Patrycja, Piotrowska, Katarzyna, Ustianowski, Przemysław, Pawlik, Andrzej, Tarnowski, Maciej
• Format: Article
• Language: English
• Subjects: Adult; B cells; Cell Line, Tumor; Complications and side effects; Development and progression; Diabetes in pregnancy; Diabetes, Gestational - metabolism; Diabetes, Gestational - pathology; Female; Gestational diabetes; Glucose; Humans; Hyperglycemia; Inflammation; Inflammation - metabolism; Inflammation - pathology; Insulin resistance; Interleukin-1beta - metabolism; Interleukins; Kinases; NF-kappa B - metabolism; Physiology; Placenta; Placenta - metabolism; Pregnancy; Proteins; Signal Transduction; Toll-Like Receptors - metabolism; Type 2 diabetes; Womens health
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms252111409

Gestational diabetes mellitus is characterised by an insufficient insulin response to hyperglycaemia and the development of insulin resistance. This state has adverse effects on the health outcomes of the mother and child. Existing hyperglycaemia triggers a state of inflammation that involves several tissues, including the placenta. In this study, we analysed the putative pathomechanism of GDM, with special emphasis on the role of chronic, sterile, pro-inflammatory pathways. The expression and regulation of the elements of IL-1β and Toll-like receptor (TLR) pathways in GDM maternal blood plasma, healthy placental explants and a choriocarcinoma cell line (BeWo cell line) stimulated with pro-inflammatory factors was evaluated. Our results indicate elevated expression of the IL-1β and TLR pathways in GDM patients. After stimulation with IL-1β or LPS, the placental explants and BeWo cell line showed increased production of pro-inflammatory IL-6, TNFa and IL-1β together with increased expression of the elements of the signalling pathways. The application of selected inhibitors of NF-ĸB, MAPK and recombinant interleukin 1 receptor antagonist (IL1RA) proved the key involvement of the IL-1β pathway and TLRs in the pathogenesis of GDM. Our results show the possible existence of loops of autocrine stimulation and a possible inflammatory pathomechanism in placentas affected by GDM.